Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

28.54
+0.16000.56%
Pre-market: 28.48-0.0555-0.19%08:17 EDT
Volume:5.41M
Turnover:154.84M
Market Cap:3.60B
PE:-6.11
High:29.06
Open:28.39
Low:28.12
Close:28.38
52wk High:43.15
52wk Low:25.77
Shares:126.00M
Float Shares:123.00M
Volume Ratio:0.81
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.81
PE(LYR):-8.94

Loading ...

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Macro World​
·
Jul 06

Cantor Fitzgerald Remains a Buy on Viking Therapeutics (VKTX)

TIPRANKS
·
Jul 01

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
Jun 25

Viking Therapeutics on Pace for Highest Close Since November 2025

Dow Jones
·
Jun 25

Analysts Are Bullish on Top Healthcare Stocks: Silexion Therapeutics (SLXN), Viking Therapeutics (VKTX)

TIPRANKS
·
Jun 25

Viking catalysts include VK3019, VK2735 readouts in Q3, says Raymond James

TIPRANKS
·
Jun 24

Viking Therapeutics: Advancing Obesity Pipeline Supports Buy Rating and Unchanged $102 Price Target

TIPRANKS
·
Jun 24

Viking Therapeutics Begins Phase 1 Testing of Investigational Weight Loss Drug

MT Newswires Live
·
Jun 24

Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019

TIPRANKS
·
Jun 24

Viking Therapeutics Says FDA Clears IND for Vk3019 Obesity Drug Trial

Reuters
·
Jun 24

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist Vk3019 in Healthy Adults

THOMSON REUTERS
·
Jun 24

Viking Therapeutics - to Initiate Phase 3 Trial of Oral Vk2735 Later This Year

THOMSON REUTERS
·
Jun 24

Viking Therapeutics - Expects to Report Vk2735 Dosing Study Results in 3Q26

THOMSON REUTERS
·
Jun 24

Viking Therapeutics (VKTX) Stock Could Be 67.2% Undervalued After Analysts Back VK2735

Simply Wall St.
·
Jun 20

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
Jun 18

Viking Therapeutics management to meet with B. Riley

TIPRANKS
·
Jun 16

Is Viking’s New CMO Appointment Reframing the VK2735 Investment Case for Viking Therapeutics (VKTX)?

Simply Wall St.
·
Jun 14

Viking Therapeutics appoints Hubert Chen as chief medical officer

Reuters
·
Jun 11

Viking Therapeutics Announces Appointment of Hubert C. Chen, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Jun 11

Viking Therapeutics files Form 3 for Chief Medical Officer Hubert C. Chen

Reuters
·
Jun 04